References
- Al-Abd AM, Al-Abbasi FA, Asaad GF, et al (2013). Didox potentiates the cytotoxic profile of doxorubicin and protects from its cardiotoxicity. Eur J Pharmacol, 718, 361-9. https://doi.org/10.1016/j.ejphar.2013.08.009
- Alhazmi MI, Hasan TN, Shafi G, et al (2014). Roles of p53 and caspases in induction of apoptosis in MCF- 7 breast cancer cells treated with a methanolic extract of Nigella sativa seeds. Asian Pac J Cancer Prev, 15, 9655-60. https://doi.org/10.7314/APJCP.2014.15.22.9655
- Alwadi HM, Baka ZAM (2001). Microorganisms asssociated with Withania somnifera leaves. Microbiological Res, 156, 303-9. https://doi.org/10.1078/0944-5013-00094
- Dar NJ, Hamid A, Ahmad M (2015). Pharmacologic overview of Withania somnifera, the Indian ginseng. Cell Mol Life Sci, 72, 4445-60. https://doi.org/10.1007/s00018-015-2012-1
- Earnshaw WC, Martins LM, Kaufmann SH (1999). Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Ann Rev Biochem, 68, 383-424. https://doi.org/10.1146/annurev.biochem.68.1.383
- Halder B, Singh S, Thakur SS (2015). Withania somnifera root extract has potent cytotoxic effect against human malignant melanoma cells. PLoS One, 10, 137498.
- HemaIswarya S, Doble M (2006). Potential synergism of natural products in the treatment of cancer. Phytother Res, 20, 239-49. https://doi.org/10.1002/ptr.1841
- Hengartner MO (2000). The biochemistry of apoptosis. Nature, 407, 770-6. https://doi.org/10.1038/35037710
- Itokawa H, Morris-Natschke S, Akiyama T, et al (2008). Plant-derived natural product research aimed at new drug discovery. J Natural Med, 62, 263-80. https://doi.org/10.1007/s11418-008-0246-z
- John J (2014). Therapeutic potential of withania somnifera: a report on phytopharmacological properties. Int J Pharmaceutical Sci Res, 5, 2131+.
- Kaur K, Rani G, Widodo N, et al (2004). Evaluation of the anti-proliferative and anti-oxidative activities of leaf extract from in vivo and in vitro raised Ashwagandha. Food Chemical Toxicol, 42, 2015-20. https://doi.org/10.1016/j.fct.2004.07.015
- Kim R, Tanabe K, Uchida Y, et al (2002). Current status of the molecular mechanisms of anticancer drug-induced apoptosis. Cancer Chemotherapy Pharmacol, 50, 343-52. https://doi.org/10.1007/s00280-002-0522-7
- Kumar AP, Graham H, Robson C, et al (2011). An overview of anticancer herbal medicines. in 'evidence-based anticancer materia medica', Eds Springer Netherlands, 1-36
- Kumar P, Kushwaha RA (2006). Medicinal evaluation of Withania somnifera (L.) Dunal(Ashwagandha). Asian J Chemistry, 18, 1401-4.
- Lee J, Sehrawat A, Singh SV (2012). Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells. Breast Cancer Res Treat, 136, 45-56. https://doi.org/10.1007/s10549-012-2239-6
- Mishra LC, Singh BB, Dagenais S (2000). Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev, 5, 334-46.
- Ouyang L, Luo Y, Tian M, et al (2014). Plant natural products: from traditional compounds to new emerging drugs in cancer therapy. Cell Prolif, 47, 506-15. https://doi.org/10.1111/cpr.12143
- Paydar M, Wong YL, Moharam BA, et al (2013). In vitro anti-oxidant and anti-cancer activity of methanolic extract from Sanchezia speciosa leaves. Pak J Biol Sci, 16, 1212-5. https://doi.org/10.3923/pjbs.2013.1212.1215
- Rahman MA, Mossa JS, Al-Said MS, et al (2004). Medicinal plant diversity in the flora of Saudi Arabia 1: a report on seven plant families. Fitoterapia, 75, 149-61. https://doi.org/10.1016/j.fitote.2003.12.012
- Samadi AK (2013). Ashwagandha: ancient medicine for modern Times. J Ancient Diseases Prev Remedies.
- Shah N, Kataria H, Kaul SC, et al (2009). Effect of the alcoholic extract of Ashwagandha leaves and its components on proliferation, migration, and differentiation of glioblastoma cells: combinational approach for enhanced differentiation. Cancer Sci, 100, 1740-7. https://doi.org/10.1111/j.1349-7006.2009.01236.x
- Skehan P, Storeng R, Scudiero D, et al (1990). New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst, 82, 1107-12. https://doi.org/10.1093/jnci/82.13.1107
- Sultana S, Asif HM, Nazar HM, et al (2014). Medicinal plants combating against cancer--a green anticancer approach. Asian Pac J Cancer Prev, 15, 4385-94. https://doi.org/10.7314/APJCP.2014.15.11.4385
- Vichai V, Kirtikara K (2006). Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc, 1, 1112-6. https://doi.org/10.1038/nprot.2006.179
- Widodo N, Takagi Y, Shrestha BG, et al (2008). Selective killing of cancer cells by leaf extract of Ashwagandha: components, activity and pathway analyses. Cancer Lett, 262, 37-47. https://doi.org/10.1016/j.canlet.2007.11.037
- Winters M (2006). Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology. Altern Med Rev, 11, 269-77.
- Yadav B, Bajaj A, Saxena M, et al (2010). In Vitro anticancer activity of the root, stem and leaves of Withania somnifera against various human cancer cell lines. Indian J Pharmaceutical Sci, 72, 659. https://doi.org/10.4103/0250-474X.78543
- Yang Z, Garcia A, Xu S, et al (2013). Withania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transition. PLoS One, 8.